Sickle cell disease: Acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de Janeiro

Revista Brasileira de Hematologia e Hemoterapia

Volumn 34, Issue 3, 2012, Pages 196-201

  Filho, Isaac Lima da Silva ^a   Ribeiro, Georgina Severo ^b   Moura, Patrícia Gomes ^c   Vechi, Monica Longo ^c   Cavalcante, Andréa Cony ^c   de Andrada Serpa, Maria José ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti HEMORIO   (Brazil)

Author keywords

Alpha thalassemia; Anemia; Clinical evolution; Haplotypes; Neonatal screening; Sickle cell

Indexed keywords

EID: 84864302450     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.5581/1516-8484.20120049     Document Type: Article

References (35)

1. Cançado RD, Jesus JA. Doença falciforme no Brasil. Rev Bras Hematol Hemoter. 2007;29(3):203-6.
2. Fleury MK. Haplótipos do cluster da globina beta em pacientes com anemia falciforme no Rio de Janeiro: Aspectos clínicos e laboratoriais. Rev Bras Anal Clin. 2007;39(2):89-93.
3. Hagar W, Vichinsky E. Advances in clinical research in sickle cell disease. Br J Haematol. 2008;141(3):346-56.
4. Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of beta-like globin cluster haplotypes. Am J Hematol. 1989;32(1):66-9.
5. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360-2.
6. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease-Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-44. Comment in: N Engl J Med. 1994;331(15):1022-3.
7. Wiearenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinicbased population study. Lancet. 2001;357(9257): 680-3
8. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle cell disease in Jamaica. Br Med J. 1982;285(6342):633-5.
9. Simões BP, Arelli JC. [Brazilian consensus meeting on stem cell transplantation: hemoglobinopathies committee]. Rev Bras Hematol Hemoter. 2010; 32 (Supl.1): 46-53. Portuguese Serjeant GR, Serjeant BE. Management of sickle cell disease; lessons from the Jamaican Cohorte Study. Blood Rev. 1993;7(3):137-45.
10. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a coort study. BMJ. 1995;311(7020):1600-2.
11. Serjeant GR, Serjeant BE. Management of sickle cell disease; lessons from the Jamaican Cohort Study. Blood Rev. 1993;7(3):137-45.
12. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995;86(2):776-83. Comment in: Blood. 1995;86(11):4382.
13. Neonato MG, Guilloud-Bataille M, Beauvais P, Bégué P, Belloy M, Benkerrou M, Ducrocq R, Maier-Redelsperger M, de Montalembert M, Quinet B, Elion J, Feingold J, Girot R. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol. 2000;65(3):155-64.
14. Fleury, MK. Determinação dos haplótipos do grupamento do gene da globina beta em pacientes com anemia falciforme no Rio de Janeiro [thesis]. Rio de Janeiro: Universidade Federal do Rio de Janeiro; 2000. 82p.
15. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103(11):4023-7.
16. Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Hematologica. 2007;92(7):905-12. Comment in: Haematologica. 2007;92(7):865-71.
17. Bruniera P. [Splenic sequestration crisis in sickle cell disease]. Rev Bras Hematol Hemoter. 2007;29(3):259-61. Portuguese.
18. Stevens MC, Hayes RJ, Vaidya S, Serjeant GR. Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood. J Pediatr. 1981;98(1):37-41.
19. Brozovic M, Davies SC, Brownell AI. Acute admissions of patients with sickle cell disease who live in Britain. Br Med J (Clin Res Ed). 1987;294(9):1206-8.
20. Kehinde MO, Marsh JC, Marsh GW. Sickle cell disease in North London. Br J Haematol. 1987;66(4):543-7.
21. Bainbridge R, Higgs DR, Maude GH, Serjeant GR. Clinical presentation of homozygous sickle cell disease. J Pediatr. 1985;106(6):881-5.
22. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997;89(5):1787-92.
23. Bailey K, Morris JS, Thomas P, Serjeant GR. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child. 1992;67(4): 517-20.
24. Klein HS. As origens africanas dos escravos brasileiros. In: Pena SD, editor. Homo brasilis. Aspectos genéticos, lingüisticos, históricos e socioantropológicos da formação do povo brasileiro. Ribeirão Preto: FUNPEC; 2002. p 93-112.
25. Hünemeier T, Carvalho C, Marrero AR, Salzano FM, Junho Pena SD, Bortolini MC. Niger-Congo speaking populations and the formation of the Brazilian gene pool: mtDNA and Y-chromosome data. Am J Phys Anthropol. 2007;133(2):854-67.
26. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ. An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alphaglobin gene number, gender, and age. Blood. 1995;85(4):1111-7.
27. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129(4):465-81.
28. Gonçalves MS, Bomfim GC, Maciel E, Cerqueira I, Lyra I, Zanette A, et al. αs-Haplotypes in sickle cell anemia patients from Salvador, Bahia, Northeastern Brazil. Braz J Med Biol Res. 2003;36(10):1283-8.
29. Sonati MF, Farah SB, Ramalho AS, Costa FF. High prevalence of α-thalassemia in a black population of Brazil. Hemoglobin. 1991;15(4):309-11.
30. Borges E, Wenning MR, Kimura EM, Gervásio SA, Costa FF, Sonati MF. High prevalence of α-thalassemia among individuals with microcytosis and hypochromia without anemia. Braz J Med Biol Res. 2001;34(6):759-62.
31. Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, et al. The interaction of alpha-thalassemia and homozygous sickle cell disease. N Engl J Med. 1982;306:1441-6.
32. Embury SH, Dozy AM, Miller J, Davis JR Jr, Kleman KM, Preisler H, et al. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med. 1982;306(5):270-4.
33. Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, Cedeno M, et al. Effects of thalassemia and microcytosis on the hematologic and vasooclusive severity of sickle cell anemia. Blood. 1984;63(6):1353-60.
34. Stevens MC, Maude GH, Beckford M, Grandison Y, Mason K, Taylor B, et al. Alpha thalassemia and hematology of homozygous sickle cell disease in childhood. Blood. 1986;67(2): 411-4.
35. Lima JC. Interação de anemia falciforme e alfa talassemia. Aspectos moleculares, clínicos, hematológicos e bioquímicos-Um estudo na população brasileira [thesis]. Rio de Janeiro: Universidade Federal do Rio de Janeiro; 1997. 170p.